§

BIODELIVERY SCIENCES INTERNATIONAL, INC. v. MONOSOL RX, LLC

10768809 - (D) (P.T.A.B. Nov. 13, 2013)
BIODELIVERY SCIENCES INTERNATIONAL, INC. v. MONOSOL RX, LLC

6 Cited authorities

  1. Fresenius USA, Inc. v. Baxter International, Inc.

    721 F.3d 1330 (Fed. Cir. 2013)   Cited 169 times   21 Legal Analyses
    Holding that "when a claim is cancelled, the patentee loses any cause of action based on that claim, and any pending litigation in which the claims are asserted becomes moot"

  2. Aspex Eyewear, Inc. v. Marchon Eyewear, Inc.

    672 F.3d 1335 (Fed. Cir. 2012)   Cited 150 times   10 Legal Analyses
    Holding that an independent claim including the limitation "magnetic member" includes ferromagnetic material in addition to a magnet, in light of dependent claim limiting "magnetic member" to a magnet

  3. Section 315 - Relation to other proceedings or actions

    35 U.S.C. § 315   Cited 544 times   889 Legal Analyses
    Permitting the Director to consolidate separate IPRs challenging the same patent

  4. Section 314 - Institution of inter partes review

    35 U.S.C. § 314   Cited 375 times   630 Legal Analyses
    Directing our attention to the Director's decision whether to institute inter partes review "under this chapter" rather than "under this section"

  5. Section 307 - Certificate of patentability, unpatentability, and claim cancellation

    35 U.S.C. § 307   Cited 117 times   10 Legal Analyses
    Stating that “a reexamination proceeding will have the same effect as that specified in section 252 for reissued patents”

  6. Section 42.108 - Institution of inter partes review

    37 C.F.R. § 42.108   Cited 45 times   69 Legal Analyses
    Permitting partial institution